Bernstein Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Raises Target Price to $44
Tandem Diabetes Care (NASDAQ:TNDM) Shareholders Have Endured a 71% Loss From Investing in the Stock Three Years Ago
RBC Capital Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $65
Diabetes Device Maker Beta Bionics Files for $100M IPO
Tandem Diabetes Care Has Signed A Multi-Year Collaboration Agreement With The University Of Virginia Center For Diabetes Technology To Advance Research And Development Efforts On Fully Automated Closed-Loop Insulin Delivery Systems
Express News | Tandem Diabetes Care Enters Multi-Year Research Collaboration With Uva Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems
